SummaryA new study reveals a slight drop in U.S. obesity rates, driven by weight loss drugs, lifestyle changes post-COVID, and regional trends. Experts caution that long-term impacts remain uncertain despite this encouraging sign.
SummaryWith FDA approval, Zevaskyn is set to be a game-changer in the treatment of recessive dystrophic epidermolysis bullosa—offering patients more than just relief, but a meaningful step toward healing.
End of Article
NEXT ARTICLE
Florida Also Lines Up To Ban Fluoride From Public Water Systems
SummaryAs the debate over fluoride in drinking water continues to unfold in Florida and other states, it is clear that the decision to fluoridate public water supplies is far from straightforward. As more states consider similar legislation, the need for careful examination of the scientific evidence surrounding fluoride’s benefits and risks will only grow.